2026-10-12T15:32:34Z https://data.mendeley.com/oai

oai:data.mendeley.com/sfjt24mwb4.1 2024-03-18T15:09:11Z

Sood, Siddhartha Characteristics and Management of Sclerosing Skin Diseases Arising During Immune Checkpoint Inhibitor Therapy: An Evidence-Based Review Mendeley Data Immune checkpoint inhibitors (ICI) are well-established for use in several cancers such as melanoma. Nonetheless, recent literature has increasingly described the onset of sclerosing skin disease (SSDs) during ICI therapy. This systematic review examines evidence regarding this phenomenon. Dermatology Dataset doi:10.17632/sfjt24mwb4.1 oai:data.mendeley.com/sfjt24mwb4.1 Creative Commons Attribution 4.0 International http://creativecommons.org/licenses/by/4.0 https://data.mendeley.com/datasets/sfjt24mwb4 2024-03-18T15:09:11Z